App-Quantinova.ai

Late Breaking Abstract - Long-term outcome of perioperative extracorporeal membrane oxygenation (ECMO) in patients undergoing pulmonary endarterectomy (PEA)

Emilia Swietlik - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

camphor

Audit of disease targeted therapies in adult patients with pulmonary arterial hypertension

Wendy Gin-Sing - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH)

Alistair Roddick - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Late Diastolic dyssynchrony: A novel method to determine RV function in pulmonary hypertension?

Timothy Crowe - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Managing pregnancy in pulmonary hypertension using a multi-professional approach: a 16-year experience in a specialist referral centre

Liesbeth ten Klooster - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Haemodynamic effects of exercise therapy in stable, optimally treated pulmonary arterial hypertension

Alison MacKenzie - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Does exercise related desaturation normalise post-pulmonary endarterectomy?

Louise Harlow - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

N/A

Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension

Logan Thirugnanasothy - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Cigarette smoke- and hypoxia-induced imbalanced vasoactive gene expression in human pulmonary artery smooth muscle cells

Abdullah Alqarni - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

Nitric oxide

The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43

Myo Htet - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

endothelin-1

Investigating redox sensitive sex differences in serotonin-induced proliferation and migration in rat pulmonary artery smooth muscle cells

Katie Yates Hood - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Superoxide dismutase

Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension

Andrew McNair - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Longitudinal cardiac changes in a SUGEN/Hypoxic Rat Model of Pulmonary Hypertension determined by Cardiac MRI

Geeshath Jayasekera - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pulmonary arterial hypertension

SU5416

Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component

Bryan Taylor - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Bone marrow transplantation reduces susceptibility to pulmonary hypertension in BMPR2 deficient mice

Alexi Crosby - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Age-Adjusted D-Dimer Cut Off: Could this prove cost-effective and safe for our Emergency Units?Authors:Mills M, Downey C , Townley S, Kasis A, Dutt T, Gautam M.Introduction:A D-dimer test result (conventionally up to 500 μg/L) is an important component of the diagnostic work-up for patients with suspected VTE, however, it is well known that D-Dimer levels rise with age. Although a negative D-Dimer in conjunction with a clinical probability score can be effective at excluding DVT/PE, studies have proposed that the use of an age-adjusted cut off can increase the number of patients excluded from further testing with a low likelihood of subsequent VTE.This study looked at unselected D-dimer requests from the Emergency department (ED) for patients with suspected DVT/PE to assess the potential impact of introducing age-adjusted D-dimer cut off limits

Azam Kasis - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

Pharmacokinetics and pre-clinical efficacy of ralinepag (APD811) in humans and rats

John Adams - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

Monocrotaline

Pulmonary embolism in England 1998-2015: increasing incidence and declining mortality

Stephen Wort - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary embolism

N/A

High prevalence of chronic breathlessness following submassive pulmonary embolism

Patrick Flood-Page - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary embolism

N/A

Reversal of pulmonary hypertension in a sugen/hypoxic rat model using an ASK1 inhibitor

Kathryn Wilson - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

GS 444217

Filters

45280 Abstracts